Last reviewed · How we verify

NCT03387202

Laparoscopic Lateral Mesh Suspension for Pelvic Organ Prolapse

Completed Last updated 7 February 2018
What this trial tests

trial testing Laparoscopic lateral suspension with mesh in Pelvic Organ Prolapse in 15 participants. Completed in 5 February 2018.

Timeline
1 November 2016
Primary endpoint
12 January 2018
5 February 2018

Quick facts

Lead sponsorFatih Sultan Mehmet Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment15
Start date1 November 2016
Primary completion12 January 2018
Estimated completion5 February 2018

Drugs / interventions tested

Conditions studied

Sponsor

Fatih Sultan Mehmet Training and Research Hospital

Who can join

18 and older, female only, with Pelvic Organ Prolapse or Pelvic Floor Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aimed to share our clinical experience in an uterine-preserving laparoscopic lateral suspension of apical prolapses with mesh operation after minor modifications in technique. Transperineal ultrasonography and several questionnaires are used for objective and subjective outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Organ Prolapse

Currently open trials in the same condition.

Other Fatih Sultan Mehmet Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03387202.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing